COVID-19 大流行期间心肌梗死住院减少的驱动因素
结果显示,2023 年 6 月 AMI 住院率为每 100 名患者 0.044 次,较 2019 年 6 月的 0.055 次低 20%;大流行早期下降与 COVID-19 死亡率呈负相关,提示回避就医,后期下降则与长期趋势一致。全大流行期间 AMI 住院 encounter 较预期少 5%(95% 预测区间 1%-9%)。
要点
- 大流行早期 AMI 住院减少可能由患者回避就医驱动。
- 2023 年 6 月 AMI 住院率仍比 2019 年 6 月低 20%。
- 全大流行期间 AMI 住院 encounter 较预期少 5%。
核心结论
- 大流行早期 AMI 住院减少可能由回避就医驱动,而截至 2023 年 6 月的持续减少可能反映长期下降趋势。
- 全大流行期间 AMI 住院 encounter 较预期少 5%(95% 预测区间 1%-9%)。
研究设计与样本
- 比较观察到的 AMI 住院 encounter 率与考虑人口特征变化和大流行前趋势(基于 2016-2019 年估计)的预期率。
主要发现
- 2023 年 6 月 AMI 住院 encounter 率为每 100 名患者 0.044 次,较 2019 年 6 月的 0.055 次低 20%。
- 大流行早期 AMI 率与 COVID-19 死亡率呈负相关,且与其他疼痛性急性病症(如肾结石)模式相似,提示与回避就医相关。
- 大流行期间超额死亡导致的人口特征变化对 AMI 下降解释很少。
- 到 2022 年 4 月,观察到的 AMI 住院 encounter 率与考虑长期下降趋势的预期率匹配。
临床怎么用
- 临床医生应关注大流行期间及之后 AMI 住院率持续低于预期的现象,警惕患者回避就医的可能。
- 对于胸痛患者,应积极评估并排除 AMI,避免因回避就医导致延误诊治。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The incidence of hospital encounters for acute myocardial infarction (AMI) decreased sharply early in the COVID-19 pandemic and has not returned to prepandemic levels. There has been an ongoing debate about what mechanism may underlie this decline, including patients avoiding the hospital for treatment, excess mortality from COVID-19 among patients who would otherwise have had an AMI, a reduction in the incidence or severity of AMIs due to pandemic-related changes in behavior, or a preexisting temporal trend of lower AMI incidence. OBJECTIVE: To describe drivers of changing incidence in AMI hospital encounters during the COVID-19 pandemic. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used traditional Medicare claims from all patients enrolled in traditional Medicare from January 2016 to June 2023 (total of 2.85 billion patient-months) to calculate the rate of AMI hospital encounters (emergency department visits, observation stays, or inpatient admissions) per capita at all short-term acute care and critical access hospitals in the United States overall and by patient characteristics. Observed rates were compared with expected rates that accounted for shifts in population characteristics and the prepandemic temporal trend (as estimated over 2016-2019). Data were analyzed in November 2023. MAIN OUTCOMES AND MEASURES: Hospital encounters for AMI. RESULTS: On average, the study sample included 31 623 928 patients each month from January 2016 through June 2023, for a total of 2 846 153 487 patient-months during the 90-month study period. In June 2023, there were 0.044 AMI hospital encounters per 100 patients, which was 20% lower than in June 2019 (0.055 encounters per 100 patients). Early in the pandemic, AMI rates moved inversely with COVID-19 death rates and tracked patterns seen for other painful acute conditions, such as nephrolithiasis, suggesting these changes were associated with care avoidance. Changes in patient characteristics driven by excess deaths during the pandemic explained little of the decline. Later in the pandemic, the decline may be explained by the long-standing downward trend in AMI incidence; by April 2022, the observed rate of encounters matched the expected rate that accounted for this trend. During the full pandemic period, from March 2020 to June 2023, there were an estimated 5% (95% prediction interval, 1%-9%) fewer AMI hospital encounters than expected. CONCLUSIONS AND RELEVANCE: The early reduction in AMI encounters was likely driven by care avoidance, while ongoing reductions through June 2023 likely reflect long-standing temporal trends. During the pandemic, there were 5% fewer AMI encounters than expected.
引用
- Wilcock, Zubizarreta, Wadhera, et al. Factors Underlying Reduced Hospitalizations for Myocardial Infarction During the COVID-19 Pandemic. JAMA Cardiol. 2024. PMID: 39083317. doi:10.1001/jamacardio.2024.2031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。